Albuterol sulfate and Norditropin drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Albuterol sulfate (albuterol sulfate) and Norditropin (somatropin recombinant). Common drug interactions include eating disorder among females and upper respiratory tract infection among males.
The phase IV clinical study analyzes what interactions people have when they take Albuterol sulfate and Norditropin. It is created by eHealthMe based on reports of 29 people who take the same drugs from the FDA, and is updated regularly.
What is Albuterol sulfate?
Albuterol sulfate has active ingredients of albuterol sulfate. It is often used in asthma. eHealthMe is studying from 77,268 Albuterol sulfate users. Check the latest studies of Albuterol sulfate.
What is Norditropin?
Norditropin has active ingredients of somatropin recombinant. It is often used in growth hormone deficiency. eHealthMe is studying from 4,920 Norditropin users. Check the latest studies of Norditropin.
29 people who take Albuterol sulfate and Norditropin together, and have interactions are studied.

What are the common drug interactions of Albuterol Sulfate and Norditropin, by gender? *:
female:
- Eating disorder
- Increased appetite
- Nausea (feeling of having an urge to vomit)
- Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
- Abdominal discomfort
- Angiopathy (generic term for a disease of the blood vessels)
- Cough
- Culture positive
- Dermatitis atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder)
- Drug ineffective
male:
- Upper respiratory tract infection
- Kidney transplant rejection
- Insomnia (sleeplessness)
- Lung infection
- Pharyngitis streptococcal (inflammation of the pharynx caused by infection from. streptococcus)
- Photosensitivity reaction
- Rash
- Pneumonia
- Sinusitis (inflammation of sinus)
- Intestinal obstruction
What are the common drug interactions of Albuterol Sulfate and Norditropin, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
- Culture positive
- Drug ineffective
- Dyskinesia (abnormality or impairment of voluntary movement)
- Dysphagia (a condition in which swallowing is difficult or painful)
- Facial paralysis (loss of function of face muscle)
- Flushing (the warm, red condition of human skin)
- Gastroenteritis viral (inflammation of stomach and intestine caused by virus infection)
- Gastrointestinal infection (infection of stomach and intestine)
- Heart rate increased
- Infusion site erythema (reddening of the skin at infusion site)
10-19:
- Kidney transplant rejection
- Pneumonia
- Sinusitis (inflammation of sinus)
- Upper respiratory tract infection
- Dermatitis atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder)
- Dry skin
- Infection
- Influenza
- Nausea (feeling of having an urge to vomit)
- Pharyngitis streptococcal (inflammation of the pharynx caused by infection from. streptococcus)
20-29:
- Intestinal obstruction
- Pancreatitis (inflammation of pancreas)
- Distal intestinal obstruction syndrome (blockage of the intestines by thickened stool and occurs in individuals with cystic fibrosis)
30-39:
n/a
40-49:
n/a
50-59:
n/a
60+:
- Abdominal discomfort
- Angiopathy (generic term for a disease of the blood vessels)
- Nausea (feeling of having an urge to vomit)
- Seizure (abnormal excessive or synchronous neuronal activity in the brain)
- Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
- Vertigo
What are the existing conditions these people have? *
- Cystic Fibrosis (disease of the secretary glands): 9 people, 31.03%
- Chronic Kidney Disease: 5 people, 17.24%
- Immune System Disorder: 3 people, 10.34%
- Hypopituitarism (diminished hormone secretion by the pituitary gland, causing dwarfism in children and premature aging in adults): 3 people, 10.34%
- Malabsorption (a state arising from abnormality in absorption of food nutrients across the gastrointestinal (gi) tract): 2 people, 6.90%
- Immunodeficiency Common Variable: 2 people, 6.90%
- Hypergammaglobulinaemia (elevated levels of gamma globulin): 2 people, 6.90%
* Approximation only. Some reports may have incomplete information.
Do you take Albuterol sulfate and Norditropin?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Albuterol sulfate (77,268 reports)
- Norditropin (4,920 reports)
Browse all drug interactions of Albuterol sulfate and Norditropin:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Albuterol sulfate:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Norditropin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Albuterol sulfate and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Norditropin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on albuterol sulfate and somatropin recombinant (the active ingredients of Albuterol sulfate and Norditropin, respectively), and Albuterol sulfate and Norditropin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Pyridostigmine Bromide cause Duodenal Ulcer Aggravated? - 4 seconds ago
- Could Varenicline Tartrate cause Hot Flushes Aggravated? - 6 seconds ago
- Could Dilaudid cause Pigmentation Disorder? - 6 seconds ago
- Could Pylera cause Heart Palpitations? - 7 seconds ago
- Multiple Sclerosis and Apallic Syndrome - 11 seconds ago
- Drug interactions of Glucosamine and Senna - 17 seconds ago
- Cleocin vs. Rocephin, side effect and effectiveness comparison - 30 seconds ago
- Could Gemcitabine cause Urine Output - Decreased? - 36 seconds ago
- Could Naratriptan cause Dizziness? - 45 seconds ago
- Could Prednisolone cause Placental Disorder? - 46 seconds ago